Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04830371
Status:
COMPLETED
Last Update Posted:
2021-10-07
First Post:
2021-03-31
Brief Title:
Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
Sponsor:
EuBiologics CoLtd
Organization:
EuBiologics CoLtd
Study Overview
Official Title:
A Phase IIIII Multicenter Observer-Blinded Randomized Non-inferiority and Safety Study of Typhoid Conjugate Vaccine EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
Status:
COMPLETED
Status Verified Date:
2021-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an observer-blinded comparative single dose clinical phase IIIII study to assess the immunogenicity and safety of EuTCV compared to Typhoid conjugate vaccine in healthy Filipino participants aged 6 months to 45 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None